309: Psychedelics At The FDA, ASCO Recap, & MorphoSys Update The Readout Loud podcast

Artwork

Drug Pricing Business Trends Business Stats

Indhold leveret af STAT. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af STAT eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

The Readout Loud « »
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update

5M ago 29:34

Del

MP3•Episode hjem

Indhold leveret af STAT. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af STAT eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

STAT colleague Meghana Keshavan joins us to dissect Lykos Therapeutics' meeting with an FDA advisory committee. We also discuss the latest news in the health and life sciences, including stories from major biotech conferences.

To learn more about Lykos' advisory committee meeting, go here; for more on the tumult at BIO, go here; for a recap of ASCO, go here; to read the latest on Novartis' acquisition of MorphoSys, go here. And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

… continue reading

332 episoder

#Drug Pricing #Business Trends #Business #Stats

Artwork

309: Psychedelics at the FDA, ASCO recap, & MorphoSys update

The Readout Loud

233 subscribers

published 5M ago

Del

MP3•Episode hjem

Indhold leveret af STAT. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af STAT eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

STAT colleague Meghana Keshavan joins us to dissect Lykos Therapeutics' meeting with an FDA advisory committee. We also discuss the latest news in the health and life sciences, including stories from major biotech conferences.

To learn more about Lykos' advisory committee meeting, go here; for more on the tumult at BIO, go here; for a recap of ASCO, go here; to read the latest on Novartis' acquisition of MorphoSys, go here. And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

… continue reading

332 episoder

#Drug Pricing #Business Trends #Business #Stats

Tutti gli episodi

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner